These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2001536)

  • 41. Hepatic metastasis from neuroblastoma.
    Halperin EC
    South Med J; 1987 Nov; 80(11):1370-3. PubMed ID: 3686139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metastatic neuroblastoma in infants: are survival rates excellent only within the stringent framework of clinical trials?
    Di Cataldo A; Agodi A; Balaguer J; Garaventa A; Barchitta M; Segura V; Bianchi M; Castel V; Castellano A; Cesaro S; Couselo JM; Cruz O; D'Angelo P; De Bernardi B; Donat J; de Andoin NG; Hernandez MI; La Spina M; Lillo M; Lopez-Almaraz R; Luksch R; Mastrangelo S; Mateos E; Molina J; Moscheo C; Mura R; Porta F; Russo G; Tondo A; Torrent M; Vetrella S; Villegas JA; Viscardi E; Zanazzo GA; Cañete A
    Clin Transl Oncol; 2017 Jan; 19(1):76-83. PubMed ID: 27041689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genomic and metabolic aspects of neuroblastomas in children under one year of age.
    Nakagawara A; Zaizen Y; Suita S
    Prog Clin Biol Res; 1991; 366():115-25. PubMed ID: 2068132
    [No Abstract]   [Full Text] [Related]  

  • 44. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.
    Ladenstein R; Philip T; Lasset C; Hartmann O; Garaventa A; Pinkerton R; Michon J; Pritchard J; Klingebiel T; Kremens B; Pearson A; Coze C; Paolucci P; Frappaz D; Gadner H; Chauvin F
    J Clin Oncol; 1998 Mar; 16(3):953-65. PubMed ID: 9508178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A review of 17 IV-S neuroblastoma patients at the children's hospital of philadelphia.
    Evans AE; Chatten J; D'Angio GJ; Gerson JM; Robinson J; Schnaufer L
    Cancer; 1980 Mar; 45(5):833-9. PubMed ID: 7260834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of patients with advanced neuroblastoma surviving more than 5 years after initiation of an intensive Japanese protocol: a report from the Study Group of Japan for Treatment of Advanced Neuroblastoma.
    Iwafuchi M; Utsumi J; Tsuchida Y; Kaneko M; Matsuyama S; Ohnuma N; Taguchi N; Mugishima H; Yokoyama J; Sasaki S; Yoshioka A; Nagahara N; Fukuzawa M; Suita S
    Med Pediatr Oncol; 1996 Dec; 27(6):515-20. PubMed ID: 8888810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children].
    Tang SQ; Huang DS; Wang JW; Feng C; Yang G
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):93-6. PubMed ID: 16613697
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Localized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for Neuroblastoma.
    De Bernardi B; Conte M; Mancini A; Donfrancesco A; Alvisi P; Tomà P; Casale F; Cordero di Montezemolo L; Cornelli PE; Carli M
    J Clin Oncol; 1995 Apr; 13(4):884-93. PubMed ID: 7707115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?
    Philip T; Zucker JM; Bernard JL; Lutz P; Bordigoni P; Plouvier E; Robert A; Roché H; Souillet G; Bouffet E
    J Clin Oncol; 1991 Jun; 9(6):1037-44. PubMed ID: 2033417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
    Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
    Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroblastoma in infants aged less than 6 months: is more aggressive treatment necessary? A report from the Pediatric Oncology Study Group of the Kyushu area.
    Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ogami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S
    J Pediatr Surg; 1995 May; 30(5):715-21. PubMed ID: 7623237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Management strategy in neuroblastoma].
    Balwierz W
    Przegl Lek; 2004; 61 Suppl 2():3-8. PubMed ID: 15686038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
    Nakagawa A; Matsuoka K; Okita H; Iwafuchi H; Hori H; Kumagai M
    Pediatr Dev Pathol; 2011; 14(2):87-92. PubMed ID: 21288077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification.
    Laprie A; Michon J; Hartmann O; Munzer C; Leclair MD; Coze C; Valteau-Couanet D; Plantaz D; Carrie C; Habrand JL; Bergeron C; Chastagner P; Défachelles AS; Delattre O; Combaret V; Bénard J; Pérel Y; Gandemer V; Rubie H;
    Cancer; 2004 Sep; 101(5):1081-9. PubMed ID: 15329919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
    Matthay KK; Perez C; Seeger RC; Brodeur GM; Shimada H; Atkinson JB; Black CT; Gerbing R; Haase GM; Stram DO; Swift P; Lukens JN
    J Clin Oncol; 1998 Apr; 16(4):1256-64. PubMed ID: 9552023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patients.
    Kushner BH; Kramer K; LaQuaglia MP; Modak S; Cheung NK
    Pediatr Blood Cancer; 2006 Mar; 46(3):278-84. PubMed ID: 16124002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastoma.
    Kushner BH; Gulati SC; Kwon JH; O'Reilly RJ; Exelby PR; Cheung NK
    Cancer; 1991 Jul; 68(2):242-7. PubMed ID: 1906368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Commentary on Kaneko et al.: Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification.
    Brodeur GM
    J Pediatr Hematol Oncol; 2002 Nov; 24(8):608-9. PubMed ID: 12439030
    [No Abstract]   [Full Text] [Related]  

  • 59. High-risk neuroblastoma in Ontario: a report of experience from 1989 to 1995.
    Klaassen RJ; Trebo MM; Koplewitz BZ; Weitzman SS; Calderwood S
    J Pediatr Hematol Oncol; 2003 Jan; 25(1):8-13. PubMed ID: 12544767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Do infants with stage IV-S neuroblastoma need treatment?
    Evans AE; Baum E; Chard R
    Arch Dis Child; 1981 Apr; 56(4):271-4. PubMed ID: 7247438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.